Skip to main content
Applied BioCode Corporation logo

Applied BioCode Corporation — Investor Relations & Filings

Ticker · 6598 ISIN · KYG0488D1051 TW Manufacturing
Filings indexed 21 across all filing types
Latest filing 2026-05-14 Interim / Quarterly Rep…
Country TW Taiwan
Listing TW 6598

About Applied BioCode Corporation

https://www.ApBioCode.com/tw

Applied BioCode Corporation is a developer and manufacturer of high-throughput multiplex molecular diagnostic solutions. The company utilizes proprietary digital biological barcode technology to facilitate the simultaneous detection of multiple pathogens from a single clinical sample. Its primary platform, the BioCode MDx-3000, supports a range of syndromic panels, including FDA-cleared assays for gastrointestinal and respiratory infections, as well as specialized tests for SARS-CoV-2, influenza, and sexually transmitted infections. Designed to optimize laboratory workflows, the system offers customizable reporting through data masking and provides cost-effective, large-scale testing capabilities. The company’s portfolio serves clinical laboratories and research institutions by providing comprehensive pathogen detection with high sensitivity and specificity.

Recent filings

Filing Released Lang Actions
115年第1季海外子公司投資
Interim / Quarterly Report Classification · 82% confidence The document is a quarterly filing from a Taiwanese listed company (ABC-KY) providing actual investment data for Q1 (115年1季) under the equity method, including shareholding ratios, original investment amounts, investment balances, and recognized profit or loss. This constitutes substantive financial data for a period shorter than a full fiscal year, fitting the definition of an Interim / Quarterly Report rather than an announcement or summary. Hence, it should be classified as IR. Q1 2026
2026-05-14 Chinese
115年第1季權益變動表
Interim / Quarterly Report Classification · 85% confidence The document text is clearly a detailed financial statement table titled “合併權益變動表” (Consolidated Statement of Changes in Equity) for the first quarter of the fiscal year (Minguo 115 Q1). It contains actual interim period financial data (equity movements by line item), not merely an announcement or link to a report. This matches the definition of an Interim / Quarterly Report. Q1 2026
2026-05-14 Chinese
115年第1季現金流量表
Interim / Quarterly Report Classification · 85% confidence The document is a consolidated cash flow statement for the first quarter (Republic of China year 115 Q1) containing detailed financial line items and actual figures. This fits the definition of an interim/quarterly report (IR) because it provides substantive financial data for a period shorter than a full fiscal year rather than merely announcing or linking to a report. Q1 2026
2026-05-14 Chinese
115年第1季綜合損益表
Interim / Quarterly Report Classification · 92% confidence The document is a detailed consolidated income statement with actual financial data for the first quarter (115年第1季) including revenue, costs, profits, and EPS metrics. It is substantive interim/quarterly financial reporting, not a short announcement or link-only notice. Therefore it is classified as an Interim/Quarterly Report (IR). Q1 2026
2026-05-14 Chinese
115年第1季資產負債表
Interim / Quarterly Report Classification · 90% confidence The document is a consolidated balance sheet (“合併資產負債表”) showing actual financial statement line items and amounts for the first quarter of the ROC Year 115 (ended 31 March). This is clearly substantive interim/quarterly financial data (not merely an announcement of a report). Accordingly, it fits the definition of an Interim/Quarterly Report (IR). Q1 2026
2026-05-14 Chinese
115年05月法人說明會簡報 — 659820260513E001.pdf
Investor Presentation Classification · 94% confidence The document is structured as a slide deck with a corporate overview, Q1 2026 highlights, business strategy, product pipeline, market positioning, leadership bios, and technology details. It reads like an investor presentation rather than a formal regulatory filing or earnings release. There is no certification letter or attached report—just detailed strategic and financial highlights for investors. This matches the definition of an Investor Presentation (Code: IP).
2026-05-13 English

Browse filings by year

1 year

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.